Canada's Patented Medicine Prices Review Board said regulations aimed at lowering drug costs would come into effect in January of next year instead of next month, as reported by CBC News.
According to the news source, the delay comes after the agency received "extensive feedback on its proposed rules."
Under proposed new rules, Canadian drug prices would be based on those from a group of countries with lower prices than the benchmark group currently used to set price ceilings.
They would also give regulators the power to review new medicines based on cost effectiveness.
The drug pricing agency said earlier this week that it would publish a new draft of the regulations later in June.
To read more NewsPoints articles, click here.